Gambia vs Indonesia: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Gambia
78.0%
in 2025
Indonesia
78.0%
in 2025
Gambia rank
117th
Indonesia rank
117th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Gambia
- Indonesia
How they compare
Gambia currently reports 78.0% against 78.0% in Indonesia, a difference of 0.0%.
The two have swapped places 6 times across 26 shared years of data; in 2000 it was Indonesia ahead.
Gambia ranks 117th and Indonesia ranks 117th of 194 countries.
Indonesia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Gambia | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 32.9% | 32.9% | Indonesia |
| 2010s | 53.8% | 61.9% | 8.1% | Indonesia |
| 2020s | 68.0% | 68.8% | 0.8% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Gambia or Indonesia?
- Gambia, at 78.0% against 78.0% in Indonesia as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Gambia and Indonesia?
- 0.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Indonesia?
- 26 years are reported by both, from 2000 to 2025.
- How do Gambia and Indonesia rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Gambia ranks 117th and Indonesia ranks 117th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.